INTRODUCTION
Gastrointestinal inflammation during inflammatory bowel diseases (IBDs) involves the activation of immune responses that lead to the release of inflammatory mediators, such as cytokines and chemokines (Strober and Fuss, 2011) . This, in turn, gives rise to recurrent visceral pain and causes the development of psychiatric comorbidities such as mood disorders (Walker et al., 2013) . Indeed, up to 80% of patients with IBD suffer from anxiety symptoms and 60% develop major depressive disorder (MDD) that often outlasts the resolution of pain symptoms and leads to an increased risk of suicide (Chen et al., 2015) . These comorbidities have a major detrimental impact on the quality of life of these patients, but the underlying cellular and molecular mechanisms have not been determined. Although symptoms of depression can potentially be treated with antidepressants (Murrough et al., 2017) , a clear unmet need is the ability to prevent the development of psychiatric disorders in patients suffering from inflammatory conditions affecting the gastrointestinal tract.
Functional magnetic resonance imaging studies in patients with IBD have revealed changes in the activity of a number of different brain regions, including the prefrontal cortex (PFC) and hippocampus (Ma et al., 2015; Bao et al., 2016) . Among these, the hippocampus is a key brain region within the limbic system that has been linked to depression in both humans and rodents (Dantzer et al., 2008) , and during depressive states, there is a dysregulation of several neurotransmitter systems such as the serotonergic, noradrenergic, and GABAergic systems. mRNA levels of specific inflammatory markers, such as for COX-2, are upregulated in the hippocampus of mice with visceral inflammation (Do and Woo, 2018) , and prolonged pharmacologically induced visceral inflammation gives rise to reduced hippocampal neurogenesis (Zonis et al., 2015) . In addition, there is an inflammatory component to depression, as evident from alterations of interleukin 1 beta (IL-1b) and tumor necrosis factor alpha (TNF-a) levels in the limbic system of patients with depression (Hodes et al., 2015) . Furthermore, anti-inflammatory drugs can be effective in treating comorbid depression-like symptoms in patients with inflammatory disorders (for review see, Hodes et al., 2015) . In rodents, both IL-1b (Ikegaya et al., 2003) and TNF-a (Batti and O'Connor, 2010) have been shown to alter synaptic plasticity in CA1 pyramidal cells.
We therefore reasoned that during visceral inflammation, central nervous system action of inflammatory cytokines released by peripherally activated leukocytes may give rise to alterations in brain function, which in turn lead to neuropsychiatric consequences such as depression. To examine this issue, we employed the dextran sodium sulfate (DSS) model of visceral inflammation. This model is pertinent as it primarily involves the innate immune response and is characterized by inflammatory cell infiltration (along with weight loss, bloody diarrhea, epithelial cell damage) and increased production of inflammatory mediators such as TNFa, IL-6, IL-1, and interferons (primarily the innate immune response) (Lopes et al., 2018) . We find that mice treated with DSS develop visceral inflammation and depression-like behaviors. Mice undergoing
RESULTS
We used a 6-day treatment of DSS in drinking water as an experimental model of inflammatory colitis in mice. This model was chosen because DSS disrupts the epithelial barrier, which causes mucosal infection from commensal bacteria and thus colonic inflammation (Lopes et al., 2018) . Compared with vehicletreated animals, DSS mice exhibited reduced body weight over the study time course of 1 month (Figure S1A ) and significant neutrophil migration to the colon up to 2 weeks following DSS discontinuation, as revealed by a myeloperoxidase assay ( Figure S1B ). Mice treated with DSS developed visceral hypersensitivity (see below) that was evident for a week following DSS treatment. Different cohorts of mice were treated with DSS and then tested for depression-related behaviors. We focused predominantly on two time periods. One set of experiments was designed to examine the early responses to DSS during the inflammatory phase, including measurements of gut permeability; measurements of leukocyte infiltration, which is expected to occur during the inflammatory phase; visceral hypersensitivity, which is known to resolve before the 4-week time point (Costa et al., 2012) ; and weight gain as a function of time after DSS treatment (up to four weeks, see above). To examine the long-term effects of DSS on behavior and associated neurochemical changes, experiments on comorbidities with depression were typically conducted 4 weeks after the discontinuation of DSS, including all critical behavioral measurements for depression, the electrophysiology, and PCR measurements. Figure S2 depicts a summary of the time lines used in this study.
Onset of Depression-Related Behaviors in Male and Female Mice
In the novelty suppressed feeding test, a conflict paradigm test based on hyponeophagia, which is among the most commonly used test for screening of novel antidepressants, both male and female mice subjected to acute visceral inflammation displayed increased latency to interact with food ( Figure 1A ). Two-way ANOVA revealed a significant difference following DSS treatment (F(1,99) = 3.3; p = 0.0058) without sex differences in our observations. The effect of DSS treatment on the loss of self-care and motivational behavior was inferred by the time spent grooming in the splash test. The results show decreased time spent grooming for DSS-treated mice ( Figure 1B ). Two-way ANOVA revealed significant differences in response to DSS treatment (F(0,64) = 3.4; p < 0.0001) and for the sex versus DSS treatment interaction (F(1.88) = 11.10; p < 0.0179). Next, we verified whether DSS treatment affects the immobility time in models of depressionrelated behavior induced by despair. Both the forced swimming test (FST) and the tail suspension test (TST) are used to evaluate depression-related behaviors in rodents, with immobility time being decreased by classical antidepressants (Steru et al., 1985) . DSS-treated mice exhibited a significantly elevated immobility time in both FST ( Figure 1C ) and TST ( Figure 1D ) compared with control groups for both sexes. Two-way ANOVA showed statistical differences in response to DSS treatment (F(1,06) = 3.4; p < 0.0001) and for the sex versus DSS treatment interaction (F(2,16) = 10.9; p < 0.0001) for FST. For the TST, a difference in response to DSS treatment was revealed (F(1,82) = 3.3; p = 0.0022). All groups of mice displayed normal ambulatory behavior in the open field when assessed at the same time points (between 3 and 4 weeks) as for the FST and TST with no differences found in the number of crossings for either DSS (H 2 O versus DSS) or sex (data not shown), thus suggesting that the depression-related behavior of DSS-treated mice was not due to motor deficits. The tricyclic antidepressant imipramine reversed the DSS effects in the TST ( Figure 1E ). Two-way ANOVA showed statistical differences following DSS treatment (F(3,82) = 8.8; p = 0.0125) and for the DSS versus imipramine treatment interaction (F(6,72) = 8.8; p < 0.0001). Collectively, our data show that mice with experimental colitis show a comorbid depression-like phenotype that is consistent with what is observed in patients with IBD. Because similar findings were obtained in both male and female mice, we focused on male mice for all ensuing experiments to reduce the numbers of mice required.
Changes in Electrophysiological Properties and Gene Expression in the Hippocampus
We then performed an electrophysiological analysis of hippocampal neuron function using hippocampal slices. We measured the magnitude of evoked inhibitory post-synaptic currents (IPSCs) in CA1 pyramidal cells in response to electrical stimulation of Schaffer collaterals at a range of stimulus intensities. We found that IPSCs recorded from pyramidal neurons of DSS-treated animals 4 weeks after DSS discontinuation were significantly increased in magnitude compared with vehicle-treated animals ( Figure 2 ). Two-way repeated measures (RM) ANOVA revealed statistical differences after DSS treatment (F(5,85) = 5.5; p = 0.0206). These data suggest the possibility that CA1 pyramidal cells may be under augmented inhibitory control and are consistent with the known involvement of the hippocampus in depressive states (Boddum et al., 2016) .
We then performed quantitative PCR analysis of hippocampal tissue at the same time point (4 weeks), and this experiment revealed an elevation of IL-1b mRNA ( Figure 3A ), but curiously no changes in TNF-a mRNA levels ( Figure 3B ). Nonetheless, the persistent upregulation of IL-1b levels suggest a sustained inflammatory process in the brains of DSS-treated mice and is consistent with previous reports implicating this cytokine in depression in rodents (Alcocer-Gó mez et al., 2017) and humans (Kolaczkowska and Kubes, 2013) . Possible microglia activation was characterized by flow cytometry. Activated microglia are identified as CD11b + CD45 intermediate -expressing cells as described previously . Analysis of total brain samples showed no activation of microglial cells 1 week following DSS discontinuation ( Figure 3C ), thus indicating that the elevated IL-1b mRNA levels are not dependent on microglial activation.
Altogether these data indicate that there are persistent changes in gene expression and functional properties in the hippocampus.
Live Imaging of Infiltrating Leukocytes into the Brain Microcirculation
Enhanced IL-1b in the brain of DSS mice and the lack of microglial activation inspired us to verify leukocyte recruitment in the brain microcirculation by using CX3CR1 GFP/WT CCR2 RFP/WT mice to track inflammatory and patrolling monocytes. These mice were additionally injected with antibody to label neutrophils. At 7 days after DSS discontinuation, there were no leukocytes in the brain microvessels of the PFC of control mice. However, DSS mice displayed a significant increase in neutrophils and both classical (CCR2 hi CX 3 CR1 low ) and patrolling (CCR2 low CX 3 CR1 hi ) monocytes ( Figure 4A , 4B, 4D, and 4E and Videos S1 and S2). Importantly, as there appeared to be no activation of microglia, this experiment further confirmed our flow cytometry analysis. Neutrophils mainly mediate tissue damage through activation by cytokines and release of oxidants, proteases, and other factors (de Oliveira et al., 2016) . They are thought to re-enter the circulation through reverse neutrophil migration, thus potentially disseminating inflammation and causing damage far away from the original site of injury (Kolaczkowska and Kubes, 2013) . The observation that an elevated number of neutrophils and monocytes were found in the brain microcirculation after inflammation of the gut supports the concept of long-lasting neuroimmune regulation of brain properties that may be correlated with the behavioral abnormalities found in DSS mice. Moreover, the inflamed blood-brain barrier (BBB) endothelium is known to exhibit increased cytokine expression such as IL-1b and TNF-a, which contribute to modulate the permeability of the BBB and the phenotype of infiltrating leukocytes (Shechter et al., 2013) .
Luteolin Prevents Leukocyte Infiltration, Visceral Pain, and Depression-Related Behavior
Flavonoids are commonly present in a wide range of plants used in traditional medicine to treat a number of disorders and often exhibit anti-inflammatory properties (Spagnuolo et al., 2018) . The bioflavonoid luteolin is found in many plants such as peppermint, artichokes, peppers, and carrots and is known to exhibit anti-oxidant, anti-microbial, anti-allergic, neuroprotective, anti-diabetic, and cardioprotective properties (Ló pez-Lá zaro, 2009). Most importantly, its potent anti-inflammatory actions have been reported both in vitro and in vivo and appear to be related to its inhibitory action of transcription factors such as nuclear factor (NF)-kB, inducible nitric oxide synthase (iNOS), and inhibition of the protein kinase B and mitogenactivated protein kinase pathways (Aziz et al., 2018) . We thus evaluated its effect on DSS-induced Figure S3 ), suggesting that locomotor dysfunctions are not major confounding factors in the interpretation of depression behaviors. We do acknowledge, however, that the FST and TST solicit abdominal muscles, which may be hypercontractile in visceral pain. Although the open-field test is not designed to detect such changes, we do note that there is likely no visceral hypersensitivity at the 4-week time point.
Luteolin Protects the Leaking Gut
Treatment of mice with DSS resulted in a decrease in transepithelial electrical resistance (TER), compared with controls 1 week from DSS discontinuation. TER is a widely used technique to quantify and determine the integrity of endothelial and epithelial tissues (Srinivasan et al., 2015) . Luteolin treatment partially rescued the DSS-induced decrease in gut resistance of colitis mice with effect evident at 50 and 60 min. DSS-treated group exhibited decreased TER in colons mounted in Ussing chambers ( Figure 6 ). Two-way RM ANOVA showed statistical difference in response to DSS treatment (F(4,17) = 12.12; p < 0.0001) and for the DSS versus luteolin treatment interaction (F(1,74) = 12.12; p < 0.0001)). These data thus suggest that the increased gut permeability during colitis can be partially reversed with luteolin.
DISCUSSION
Inflammation and the immune system have emerged as important components of MDD (Hodes et al., 2015) and are thought to serve as an induction mechanism of depression-related behaviors (Walker et al., 2013) . Our data reveal that behavioral abnormalities also arise following acute inflammation of the gut and are associated with changes in electrophysiological properties of the hippocampus and activation of neuroimmune responses. The persistent upregulation of IL-1b levels observed in our study is consistent with multiple reports implicating this cytokine in depression and suggests a sustained neuroinflammatory process following peripheral inflammation that can be mediated by circulating leukocytes.
Although microglia are well characterized as an important source of IL-1b during neuroinflammation (Liu and Quan, 2018) , our flow cytometry analysis suggests a different source other than the resident microglia in the brain for the elevated levels of IL-1b in the hippocampus. Our in vivo intravital microscopic studies revealed an increase in the infiltration of neutrophils and monocytes of both subtypes into cerebral microvasculature, which are consistent with the higher levels of IL-1b that we observed. After peripheral trauma or infection, neutrophils increase in number, and this is followed by an increase in monocytes that are recruited to the site of inflammation (Ginhoux and Jung, 2014) . Neutrophil recruitment is initiated by changes in the surface of the endothelium as a result of stimulation by inflammatory mediators released from tissueresident sentinel leukocytes. Neutrophils then facilitate the recruitment of monocytes into inflamed tissues (Kolaczkowska and Kubes, 2013) . Monocytes might further contribute to inflammation but may also partake in its resolution (Ginhoux and Jung, 2014) . These cells are able to re-enter the vasculature where they may be involved in spreading the inflammatory processes to other organs (Kolaczkowska and Kubes, 2013; de Oliveira et al., 2016) , including immune-privileged sites, such as the brain (Shechter et al., 2013) . The correlation between the peripheral immune system and depression is further supported by early studies showing increased neutrophils and ly6C hi monocytes in the blood of patients diagnosed with MDD (Smith, 1991; Maes, 1995) and by a more recent postmortem study that revealed an elevated number of peripheral monocytes in the brains of patients with depression (Torres-Platas et al., 2014) .
The connection between depression and visceral inflammation appears to be bidirectional. In a mouse depression model based on reserpine-induced monoamine depletion, depression aggravated intestinal inflammation by altering tonic vagal inhibition of inflammatory cytokines (Ghia et al., 2008) . Along these lines, depression induced by either bulbectomy or reserpine reactivates inflammation following chronic colitis (Ghia et al., 2009) . Stress was also found to induce immune reactions and alter gut microbiota, thus sensitizing DSS-treated mice and modulating mood behaviors, along with increased infiltration of B cells, neutrophils, and proinflammatory macrophages in colonic lamina propria (Gao et al., 2018) . On the other hand, acute colitis in rats induced by DSS produced both pain and anxious depressive behaviors when assessed 1-2 weeks following DSS discontinuation (Chen et al., 2015) , which is qualitatively consistent with our findings presented here.
It is estimated that 30%-50% of patients with depression are refractory to treatment with classical antidepressants, thus it becomes evident that distinct mechanisms are involved in this pathology (Krishnan and Nestler, 2008) and highlights the necessity of alternative strategies for therapeutic interventions. In this context, bioflavonoids have emerged as natural sources for new therapeutics (Katiyar et al., 2012) . Luteolin is a flavone present in medicinal plants, vegetables, and fruits, such as peppermint, artichoke, celery, broccoli, onions, and peppers among others (Aziz et al., 2018) . Besides its anti-oxidant, anti-microbial, anti-diabetic, anti-allergic, and neuroprotective actions, luteolin has potent anti-inflammatory properties in vivo and in vitro mainly due to due to inhibition of nitric oxide production and the expression of nuclear factor NF-kB, which controls the production of inflammatory cytokines such as IL-1b (Seelinger et al., 2008; Aziz et al., 2018) . Luteolin has been reported to be neuroprotective and to have antidepressant-like action when delivered orally to mice (Ishisaka et al., 2011) . It also produced analgesia in an animal model of neuropathic pain when delivery spinally, but not supraspinally (Hara et al., 2014) . Luteolin treatment did not inhibit neutrophil migration to the colon of DSS mice when analyzed 1 week following DSS discontinuation (data not shown); however, the intestinal anti-inflammatory action of luteolin was previously described in DSS-treated mice. Following systemic delivery, luteolin inhibited macrophage infiltration into the colonic mucosa, produced anti-inflammatory activity in the intestine, and improved disease activity index (DAI), such as colon shortening and histological damage assessments (Nishitani et al., 2013) . It also significantly reduced DAI in the colon of DSS-treated mice; reduced the expression of mRNA for several pro-inflammatory mediators such iNOS, TNF-a, and IL-6; and increased the activities of colonic antioxidant factors such as Nrf2, SOD, and CAT (Li et al., 2016) . These data are consistent with our findings showing that repeat dosing of systemically delivered luteolin prevents leukocyte infiltration into the brain, abolishes visceral hypersensitivity, and prevents the development of abnormal behaviors associated with depression.
Altogether, our findings reveal that acute visceral inflammation results in increased infiltration of leukocytes into the brain microvasculature and gives rise to depression-like behavior that is consistent with sustained neuroinflammation. Protecting the inflamed gut with the flavonoid luteolin prevents gut leakage and reverses behavioral abnormalities such as pain and depression. Thus the present study sheds light into the mechanisms that underlie the development of these comorbid conditions and suggest new ways for therapeutic intervention for the treatment of depression associated with visceral inflammation.
Limitations of the Study
It is important to recognize that the DSS model does not entirely reflect the etiology of human colitis (Chassaing et al., 2014) . A second caveat is that although we examine changes in hippocampal function at the Figure 6 . Luteolin Reverses DSS-Induced Changes in Gut Permeability Luteolin attenuates intestinal epithelial barrier dysfunction induced by DSS in mice. The distal colon was mounted in Ussing chambers after luteolin treatment (15 mg/kg, intraperitoneally daily, 15 days), and TER was measured for 60 min 1 week after DSS discontinuation. Circles represent mean G SEM (n = 9-11). Two-way RM ANOVA reveals a significant effect of luteolin treatment. aa p < 0.01, aaa p < 0.001, aaaa p < 0.0001 H 2 O-versus DSS-treated groups; *p < 0.05 luteolin-versus vehicle-treated groups.
iScience 16, 12-21, June 28, 2019cellular level, the intravital microscopic experiments do not allow access to deep brain structures such as the hippocampus, and instead are conducted in the PFC. We believe that the findings obtained in this brain structure are also relevant to hippocampal function.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file. to water and food unless specified elsewhere. Experiments were carried out between 10am and 2pm. When the same cohorts of mice were used for behavioural analysis, they were tested first on the less stressful test and always obeying a 3 days minimum interval between testing sessions and each animal was tested only once (for example: they were first tested on the open field apparatus, then 3 days later tested on forced swimming test; or they were first tested on splash test, then tested on tail suspension test). Female and male mice were tested in separate groups. For cell biology experiments and behavioural assessments examining the in vivo actions of Luteolin or the positive control imipramine, only male mice were used. For all behavioural studies animals were tested in randomized trials.
DATA AND SOFTWARE AVAILABILITY

Reagents and treatment
Dextran sodium sulfate (DSS, Affymetrix) was prepared in autoclaved water and administered in drinking water for 6 consecutive days. Luteolin (15 mg/kg, Tocris)
and Imipramine (Sigma-Aldrich) were suspended in DMSO (5%), diluted in sterile PBS and administered intraperitoneally (i.p.). Luteolin was delivered chronically once a day for 15 days starting 2 days before beginning of the 6 days DSS treatment protocol.
Colorectal distention and electromyographic recording
Evaluation of colonic hypersensitivity was performed as pain index. Three days prior to colorectal distention, two electrodes were implanted in the abdominal external oblique musculature of mice anesthetized Isoflurane. Electrodes were exteriorized at the back of the neck and protected by a plastic tube attached to the skin. In the experimental day, animals were allowed to acclimate in the room and implanted electrodes were connected to a Bio Amp, which was connected to an 
Novelty suppressed feeding test
This test is used specifically for evaluating levels of anhedonia as a feature of depression. Animals were food-deprived for 24 h and thereafter introduced to a novel 40 x 60 x 50 cm arena with wood shavings floor (same as housing cages) and with a single pellet of food placed in the centre of the arena. Animals were individually placed in a corner of the arena backwards to the walls and the latency of each mouse to interact with the food pellet was recorded. After the test, animals were immediately returned to its home cage.
Splash test
The Splash Test is based on grooming behaviour and used to access depressivelike behaviour of mice. The grooming behaviour was scored during 5 min after spraying a 10% sucrose solution on the dorsal coat of the mice.
Forced swimming test
Mice were individually allowed to swim in an open cylindrical container (diameter 10cm x height 25cm), containing 19 cm of water at 24±1 •C; the total duration of immobility during a 6 min test was scored. A mouse was considered to be immobile when it stops moving its limbs in any kind of swimming action and remains motionless floating in the water, while making the necessary movements with its tail to keep the head above the water. Immobility time was timed for the entire 6 min they spend in the water. Animals were never allowed to drown during the test.
Tail suspension test
Mice were both acoustically and visually isolated and individually suspended 50cm above the floor with adhesive tape placed approximately 1cm from the tip of the tail.
Immobility time of mice was quantified when a mouse stopped struggling and remained without any body movement (total immobility time) for 6 min.
Open field test
An open field test was used exclusively to access locomotor activity of mice to validate the forced swimming and tail suspension tests. The apparatus consists of a wooden box measuring 40 × 60 × 50 cm with a frontal glass wall. The floor of the arena is divided into 12 equal squares and placed in a sound free room. Animals were placed in the rear left square and allowed to explore freely for 6 minutes.
Crossings reflect the number of grid lines that were crossed with all paws (crossing).
The apparatus was cleaned with a 70% alcohol solution and dried after each individual mouse session.
Electrophysiological recording (eIPSCs) of CA1 pyramidal cells
Four weeks after discontinuation of DSS treatment, acute coronal brain slices (300 µm) containing CA1 region were obtained from C57BL/6J (DSS-or H 2 0-treated) mice using a vibratome (Leica VT1200S, Leica Biosystems) in an ice-cold NMDGbased solution (Ting et al., 2014) . Brain slices were first incubated at 33.5°C in NMDG-based solution for 11 min, then in normal external solution for 50 min, and finally transferred to room temperature in normal external solution for at least 1hr before recording. Whole cell patch clamp recordings were performed in pyramidal neurons (pyramidal layer) in CA1 area using MultiClamp 700B and Digidata 1440A (Molecular Devices). Normal external solution contained (mM): NaCl 120, NaH2PO4 All chemicals were purchased from Sigma.
Real time quantitative RT-PCR measurements
Mice were killed by decapitation and hippocampi were rapidly dissected at 0-4 °C and immediately flash frozen to be stored at -80 °C. Total RNA was extracted using the NucleoSpin RNA II extraction kit (Macherey-Nagel) and quantified using a NanoDrop. First-stranded cDNA synthesis (from 1 µg total RNA per 20 µl of reaction mixture) was carried out using QuantiTect® Reverse Transcription Kit (Qiagen). PCR amplification, in triplicate for each sample, was performed using the QuantStudio 3
Real-Time PCR System and TaqMan® Universal PCR Master Mix No AmpErase® UNG (Thermo Fisher Scientific). Semi-quantitative determinations were made for the target genes IL1-beta (Mm00434228_m1) and TNF-alpha (Mm00443258_m1) with reference to the reporter genes encoding GAPDH (Mm99999915_g1) and ACTB (Mm00607939_s1). The polymerase activation step at 95°C for 15 min was followed by 40 cycles of 15 s at 95°C and 60 s at 60°C. The validity of the results was checked by running appropriate negative controls (replacement of cDNA by water for PCR amplification; omission of reverse transcriptase for cDNA synthesis). Specific mRNA levels were calculated after normalizing from GADPH and ACTB mRNA in each sample using the 2(-Delta C(T)) method. Data are presented as relative mRNA units compared to control values.
Flow cytometry
Assessment of microglia activation by flow-cytometry was performed in brain cells isolated using a previously described protocol 
Intravital imaging
Intra-vital microscopy was performed using established procedures and according to Andonegui and colleagues . Mice were anesthetized via intraperitoneal delivery of 200 mg/kg ketamine and 10 mg/kg of xylazine. The jugular vein was then cannulated to administer labeled antibodies. Mice were positioned under an infrared heat lamp to maintain body temperature and their heads were shaved prior to craniotomy using a high-speed drill. After removal of the dura mater the brain was alive and fully perfused, and the animals were placed on an upright spinning disk confocal microscope. Neutrophils in the brain microvasculature were visualized using an anti-mouse Ly6G mAb conjugated to APC (clone 1A8, BioLegend, San Diego, CA, USA). The vascular endothelium was visualized using anti-mouse CD31 mAb conjugated to PE (clone 390, eBiosciences, San Diego, CA, USA). The antibodies were delivered via intravenous injection. CCR2 positive inflammatory monocytes and CX3CR1 positive patrolling monocytes were identified in heterozygous CX3CR1 GFP/WT CCR2 RFP/WT knock-in mice using an Olympus BX51WI upright microscope. The instrument is equipped with a confocal light path based on a modified Yokogawa CSU-X1 head with a 20x/0.95W(LUMPLANFL)
water immersion objective. Up to three laser excitation wavelengths (491, 561, and 640 nm; Cobalt) were used in rapid succession for imaging of the three types of immune cells. A back-thinned EM-CCD 512 × 512 pixel camera was used for fluorescence detection. Volocity® software was used for acquisition and analysis.
The number of rolling and adherent neutrophils and monocytes were determined offline. Adherent neutrophils and monocytes were considered the cells that remained stationary for longer than 30 seconds.
Ussing chambers and transepithelial electrical resistance (TER)
Mice were euthanized, distal colons were removed, and opened longitudinally along the mesenteric border. They were rinsed in cold ( 
Determination of myeloperoxidase (MPO) activity
MPO activity (a marker of neutrophil infiltration) was measured according to a protocol previously described (De Young et al., 1989) . Colons were homogenized Gadotti et al -supplementary material, 12 with 220 mM sodium phosphate, pH 7.4 and centrifuged at 9,000 × g for 20 min at 4 °C. The pellet was re-suspended in 80 mM sodium phosphate buffer (pH 5.4) containing 0.5% hexadecyltrimethylammonium bromide (HTAB), and again centrifuged at 11,000 × g for 20 min at 4 °C. MPO activity of supernatants was determined at 650 nm in presence of 0.017% H₂O₂ and 3,3',5,5'-tetramethylbenzidine (TMB, 18.4 mM) and expressed as MPO activity/100 mg of tissue.
Statistical analysis
Data were analyzed with Graphpad Prism 6.0., Synaptosoft or Clampfit and are presented as the mean ± SEM. In vivo and intravital microscopy data were analyzed by one-or two-way analysis of variance (ANOVA) or by Repeated Measures (RM)
ANOVA followed by a Newman-Keuls post hoc test. Unpaired t tests and one way ANOVA with Bonferroni's correction for multiple comparisons tests were used in comparison of electrophysiological data. Evoked IPSC (eIPSC) data were analyzed using the Mini Analysis Program (Synaptosoft) and Clampfit (Molecular Devices).
Unpaired t tests were also used for analysis of qPCR data. For gut permeability and MPO assays statistical analysis were performed using two-way ANOVA followed by Dunnett´s multiple comparison test. Statistical significance was accepted at the level of p < 0.05.
